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Abstract
Circulating triglyceride-rich lipoproteins (TGRL) from hypertriglyceridemic subjects exacerbate endothelial
inflammation and promote monocyte infiltration into the arterial wall. We have recently reported that TGRL isolated
from human blood after a high-fat meal can elicit a pro- or anti-atherogenic state in human aortic endothelial cells
(HAEC), defined as up- or down-regulation of VCAM-1 expression in response to tumor necrosis factor alpha (TNFα)
stimulation, respectively. A direct correlation was found between subjects categorized at higher risk for
cardiovascular disease based upon serum triglycerides and postprandial production of TGRL particles that increased
VCAM-1-dependent monocyte adhesion to inflamed endothelium. To establish how TGRL metabolism is linked to
VCAM-1 regulation, we examined endoplasmic reticulum (ER) stress and the unfolded protein response (UPR)
pathways. Regardless of its atherogenicity, the rate and extent of TGRL internalization and lipid droplet formation by
HAEC were uniform. However, pro-atherogenic TGRL exacerbated ER membrane expansion and stress following
TNFα stimulation, whereas anti-atherogenic TGRL ameliorated such effects. Inhibition of ER stress with a chemical
chaperone 4-phenylbutyric acid decreased TNFα-induced VCAM-1 expression and abrogated TGRL’s atherogenic
effect. Activation of ER stress sensors PKR-like ER-regulated kinase (PERK) and inositol requiring protein 1α
(IRE1α), and downstream effectors including eukaryotic initiation factor-2α (eIF2α), spliced X-box-binding protein 1
(sXBP1) and C/EBP homologous protein (CHOP), directly correlated with the atherogenic activity of an individual’s
TGRL. Modulation of ER stress sensors also correlated with changes in expression of interferon regulatory factor 1
(IRF-1), a transcription factor of Vcam-1 responsible for regulation of its expression. Moreover, knockdown studies
using siRNA defined a causal relationship between the PERK/eIF2α/CHOP pathway and IRF-1-mediated VCAM-1
expression. We conclude that ER stress and the UPR contribute to the regulation of Vcam-1 transcription as a
function of the atherogenic nature of TGRL.
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Introduction
The composition of circulating triglyceride-rich lipoproteins
(TGRL) in blood undergoes dynamic changes with an
individual’s diet and lipid metabolism. TGRL consist of proteins
and lipids, and their relative amounts and organization
determine particle size and density. Particle composition in turn
determines its residence time in circulation and the rate of
uptake and transport across the endothelium, which directly
impact atherogenesis [1]. Hypertriglyceridemia prevails in
obese individuals and is directly correlated with the growing
epidemic of type 2 diabetes mellitus (T2DM) and increased risk
for cardiovascular diseases (CVD) [2]. TGRL from
hypertriglyceridemic subjects is thought to exacerbate
endothelial inflammation and promote monocyte infiltration into
the arterial wall, two early events in the formation of
atherosclerotic lesions [3]. Following consumption of a high-fat
meal, hypertriglyceridemic subjects produced TGRL particles of
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larger diameter with increased content of apolipoprotein
(Apo)CIII, cholesterol, and triglycerides, and a distinct fatty acid
composition [4,5]. Uptake of these TGRL by human aortic
endothelial cells (HAEC) amplified upregulation of membrane
vascular cell adhesion molecule 1 (VCAM-1), which correlated
with an increase in shear resistant monocyte adhesion
compared with tumor necrosis factor alpha (TNFα) stimulation
alone. Conversely, TGRL with low triglyceride content exerted
an athero-protective effect on HAEC, lowering VCAM-1
expression and the extent of monocyte recruitment [4,6,7]. A
key question remains as to the origin of this heterogeneity in
the inflammatory response to TGRL derived from individuals
following a high-fat meal. Specifically, how does uptake and
processing of TGRL by the various organelles in endothelial
cells (EC) result in differential impact on signaling pathways
that converge on a pro- versus anti-atherogenic response?
TGRL and low density remnant particles are promptly taken
up by EC via endocytosis through low density lipoprotein (LDL)
family receptors, predominantly low density lipoprotein
receptor-related protein 1 (LRP-1) and LR11 (LDL receptor
relative with 11 binding repeats) [4,8]. Excess fatty acids and
sterols released by lipoprotein metabolism are mainly
converted to neutral lipids and packaged into lipid droplets (LD)
for storage by endoplasmic reticulum (ER). Some metabolic
intermediates ultimately enter ER synthesis pathways for
phospholipids, a major component of ER and LD membranes
[9]. In addition to lipid metabolism, the ER plays a crucial role in
protein synthesis [10]. Disruption of ER homeostasis leads to
accumulation of unfolded or misfolded proteins in the ER
lumen, a condition referred to as ER stress. This condition has
emerged as a common signature of metabolic dysregulation as
indicated by studies that link obesity to insulin resistance and
inflammation in T2DM and CVD [11-13]. A high-fat diet in
obese animal models and in obese humans induces marked
elevation of ER stress in the liver and adipose tissues, as well
as in atherosclerotic lesions [12,14,15]. The mechanism is not
entirely known, but is associated with prolonged activation of
the ER stress pathway in response to oxidative stress,
oxysterols, and elevated levels of intracellular cholesterol and
saturated fatty acids in macrophages and endothelial cells [16].
Mitigation of ER stress with the chemical chaperone 4-
phenylbutyric acid (4-PBA) has proven effective in alleviating
obesity-induced ER stress and insulin resistance in type 2
diabetic mice, and in reducing atherosclerotic lesion
progression in high-fat diet fed ApoE-/- mice [17,18]. Still elusive
is how the uptake and metabolism of native TGRL exerts a
differential inflammatory effect on endothelium and whether ER
stress contributes to its atherogenicity.
Endothelial and other somatic cells have adapted
mechanisms to mitigate ER stress and to maintain
homeostasis known as the unfolded protein response (UPR),
which involves dissociation of binding immunoglobulin protein
(BiP) from the three ER transmembrane sensor proteins, PKR-
like ER-regulated kinase (PERK), inositol requiring protein 1α
(IRE1α), and activating transcription factor 6 (ATF6), and their
subsequent activation. These in turn activate downstream
effectors, such as spliced X-box-binding protein 1 (sXBP1) and
C/EBP homologous protein (CHOP) [19-21]. Apart from being a
rescue mechanism under ER stress, some particular UPR
pathways play a crucial role in the regulation of adipogenesis
and EC inflammation [22,23]. For example, the IRE1α-sXBP1
branch of the UPR mediates interleukin (IL)-8, IL-6, and
monocyte chemoattractant protein-1 (MCP-1) expression by
HAEC following activation with oxidized LDL [23]. Another
subarm of the UPR, the PERK-eukaryotic initiation factor-2α
(eIF2α) pathway, is activated in animal models of obesity. Its
downstream target CHOP is highly expressed in atherosclerotic
plaques and reported to mediate ER stress-induced
upregulation of inflammation and adhesion related proteins in
macrophages and smooth muscle cells, in addition to its
traditional pro-apoptotic role [24,25]. Thus, a constellation of
evidence points to UPR and ER stress being directly
associated with the inflammatory axis of atherogenesis. Yet it is
unknown whether and to what extent they are engaged in the
modulation of endothelial inflammation as a function of an
individual’s TGRL.
We hypothesized that the relative capacity of TGRL to
influence transcription and expression of VCAM-1 is a function
of particle metabolism, in particular its influence on ER stress.
Our objective was to investigate a role for ER stress in TGRL-
modulated endothelial dysfunction using a model for
hypertriglyceridemia. To that end, we assessed TGRL
harvested from low- and high-risk subjects (e.g. based upon
serum triglyceride level) fed a high-fat meal and examined ER
stress and UPR signaling pathways in the transcriptional
regulation of VCAM-1 expression following EC inflammation
stimulated by TNFα. We demonstrate that native TGRL edits
inflammatory VCAM-1 expression via UPR pathways.
Materials and Methods
Human subjects and study meal
Volunteers were recruited under informed written consent
according to a protocol approved by the Institutional Review
Board at the University of California, Davis. The study included
both normal subjects and individuals with hypertriglyceridemia
(fasting serum triglycerides > 150 mg/dL), and excluded those
on lipid-lowering or anti-inflammatory medications or with a
fasting blood glucose > 110 mg/dL. Venous blood was
collected after a 12-hour overnight fast and again 3.5 hours
after a standardized moderately high-fat meal (1230 calories,
47% from fat; 32% of total fat is saturated fat) [4]. Fasting and
postprandial serum lipid and glucose levels were determined
by the UC Davis Medical Center Clinical Laboratory using the
Beckman Coulter UniCel DxC 800 Synchron Clinical System.
LDL cholesterol was calculated by the Friedewald equation
[26].
TGRL isolation and characterization
TGRL (ρ < 1.0063 g/ml) were isolated from postprandial
blood samples by ultracentrifugation, and normalized for ApoB
content quantified by ELISA (Alerchek), as previously
described [8]. The isolates tested negative for endotoxin by
chromogenic test kit (Associates of Cape Cod). They were
aliquoted under nitrogen at 4°C for immediate use. Particle size
distribution was measured using a Nanotrac Particle Size
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Analyzer equipped with FLEX software (Microtrac Inc.) as
described previously [4]. More than 95% of the isolated TGRL
particles were categorized as very-low-density lipoproteins
(VLDL) based on particle diameter. For each subject’s sample,
lipid and apolipoprotein concentrations (total cholesterol,
triglycerides, ApoB, ApoCIII and ApoE) were measured by
spectrophotometric assay using a clinical chemistry analyzer
(Polymedco Inc.).
HAEC culture and TGRL treatment protocol
Low passage HAEC (passage 4-6) (Genlantis) were cultured
on collagen-coated (50µg/ml, Clontech) culture dishes or
gelatin-coated (1%) coverslips and maintained in Endothelial
Cell Growth Medium-2 (EGM®-2, Lonza) supplemented with 1x
antibiotic-antimycotic solution (Invitrogen). Unless otherwise
indicated, HAEC were treated with TNFα (0.3 ng/ml, R&D
system) alone or simultaneously with individual freshly isolated
TGRL (10 mg ApoB/dL) for 4 hours. To quantify inflammatory
activation relative to TNFα alone, HAEC were detached using
enzyme-free cell dissociation buffer (Gibco), labeled with
fluorescein-conjugated antibodies to human intercellular
adhesion molecule 1 (ICAM-1) or VCAM-1, and analyzed by a
FACScan flow cytometer (Becton Dickinson) [4]. Median
fluorescence intensity (MFI) was quantified using FlowJo
software (TreeStar, Ashland, OR) and used for further analysis.
Antibodies
For flow cytometry, the following antibodies from R&D
systems were used: hVCAM-1 FITC mAb (BBA22), hICAM-1
FITC mAb (BBA20), and IgG fluorescein isotype controls
(IC002F and IC003F). For Western blotting, the following
antibodies were used: BiP (ab21685), phospho-IRE1α
(ab48187), and IRF-1 (ab55330) from Abcam; total IRE1α
(3294), total-eIF2α (2103), phospho-eIF2α (3597), CHOP
(5554) from Cell Signaling Technology; sXBP1 (sc-32138) and
Tubulin (sc-53646) from Santa Cruz Biotechnology; and
GAPDH (NB-300-328) from Novus Biologicals. For
immunofluorescence staining of ER structure, goat anti-human
calreticulin antibodies (SC-6468) from Santa Cruz
Biotechnology and Alexa Fluor® 546 rabbit anti-goat IgG
(A-21085) from Life Technologies were used.
TGRL labeling and uptake assay
TGRL were conjugated to Alexa-Fluor 488 (AF488) using a
protein labeling kit (Invitrogen) as described previously [4], and
stored at 4°C, protected from light. For the uptake assay,
HAEC were incubated with AF488-TGRL (10 mg ApoB/dL in
phenol red-free culture media) at 37°C for the designated
period, washed twice with Hank's Balanced Salt Solution
(HBSS, w/Ca2+, Life Technologies), detached using TrypLE
Express (Life Technologies), pelleted at 1,000 g at 4°C, and
resuspended in HBSS (w/Ca2+ + 0.2% human serum albumin)
on ice. The samples were immediately analyzed by a FACScan
flow cytometer (Becton Dickinson) with CellQuest software.
Data represent MFI from a single Gaussian population of
10,000 cells for each sample.
Lipid droplet staining and imaging
HAEC were incubated with TGRL (10 mg ApoB/dL) for the
indicated period, washed with 37°C HBSS w/ Ca2+, and
incubated with BODIPY 493/503 (Life Technologies, 2 µM in
HBSS) at 37°C for 1 min. HAEC were washed with ice cold
HBSS, collected using TrypLE Express, and analyzed by a
FACScan flow cytometer. Samples were protected from light
throughout these procedures. Data represent MFI from a single
Gaussian population of 10,000 cells for each sample. For
visualization of LD by confocal microscopy, HAEC were
cultured on 1% gelatin-coated coverslips, incubated with TGRL
for 4 hours, and stained with BODIPY as described above.
Cells were maintained in phenol red-free Leibovitz-15 medium
(Life Technologies) at 37°C, and imaged under 488nm laser
excitation by a Zeiss LSM 5 Pascal confocal microscope.
Immunofluorescence
HAEC were grown on 1% gelatin-coated coverslips to 80%
confluence. After treatment, cells were rinsed with phosphate-
buffered saline (PBS), fixed and permeabilized with 100%
methanol at -20°C for 6 min. The coverslips were then rinsed
with PBS and blocked in 5% bovine serum albumin (BSA) +
0.2% Triton X-100 in PBS. HAEC were then incubated with
goat anti-human calreticulin antibody (1 µg/ml) in PBS w/ 1%
BSA for 1 hour at room temperature, washed with PBS, and
incubated with Alexa Fluor 546 rabbit anti-goat IgG (2 µg/ml) in
PBS at room temperature for 1 hour. Nuclei were
counterstained with Hoechst (Sigma). The samples were
imaged using a Zeiss LSM 5 Pascal confocal microscope.
Images were analyzed using ImageJ. The coefficient of
variation (CV) in the pixel fluorescence intensity of labeled
calreticulin in the cytoplasm of each cell, a global index of
spatial heterogeneity, was applied to assess ER morphological
changes. Cells with expanded ER yielded higher CV values as
calreticulin became less evenly distributed [27]. 30-40 cells
were analyzed for each condition.
RNA isolation and quantitative RT-PCR
Total RNA was isolated using the High Pure Total RNA
isolation kit (Roche), which includes a DNase digestion step to
remove contaminating genomic DNA. RNA (~500 ng) was
converted to 1st strand cDNA using the Transcriptor First
Strand cDNA Synthesis kit (Roche). Quantitative PCR was
performed using TaqMan Gene Expression Assays (Applied
Biosystems, VCAM-1: Hs00365485_m1; ICAM-1:
Hs00164932_m1; RPLP0: Hs99999902_m1; IRF-1:
Hs00971960_m1) and TaqMan Gene Expression Master Mix
(Applied Biosystems) with a RealPlex Mastercycler
(Eppendorf). Quantification relative to the housekeeping gene
acidic ribosomal protein P0 (RPLP0) was determined by the
ΔΔCt method, where Ct is threshold cycle number.
Protein extraction and Western immunoblot analysis
Cells were lysed in radio immunoprecipitation assay (RIPA)
buffer containing 1 mM NaF, 1 mM sodium orthovanadate and
protease inhibitor cocktail (Sigma) with freshly added 0.1 mM
phenylmethanesulfonylfluoride (PMSF). The lysate was
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sonicated and protein concentration determined by the
bicinchoninic acid (BCA) assay. Samples were normalized to 1
mg/ml of protein content, and resolved by SDS-PAGE,
transferred to nitrocellulose, and blocked. The blots were
incubated overnight at 4°C with primary antibody, then at room
temperature for 1.5 hours with horseradish peroxidase-
conjugated secondary antibody. They were developed with
Chemiluminescent Substrate. Signals were captured by
ChemiDoc MP gel imaging system (Bio-Rad). Tubulin, GAPDH
or the total protein forms of phosphorylated proteins of interest
served as the loading control for quantification using ImageJ
[5].
Cell Transfection
To deplete CHOP or sXBP1 expression, cells (5×105) were
transfected with 150 pmol siRNA to CHOP or XBP1 (Santa
Cruz Biotech), using a 4D-Nucleofector system (Lonza). After
48-96 hr, cells were treated as described followed by Western
blot or flow cytometry analysis.
NF-κB and activator protein-1 (AP-1) activation
NF-κB and AP-1 activities were measured by ELISA
targeting active phospho-p65 and phospho-c-Jun in the nuclear
extract as previously described [5].
Statistical analysis
Data were analyzed using GraphPad Prism v5.0 software. All
data are presented as mean ± standard error (SE) unless
otherwise indicated. Differences among multiple groups were
assessed by one-way ANOVA with a post hoc Newman-Keuls
test. Two experimental groups were compared using Student’s
t test, with pairing where appropriate. Comparisons were
considered significant for 2-tailed p values < 0.05. Correlations
between groups were assessed using Pearson's correlation
coefficient (r).
Results
TGRL uptake induces extensive lipid droplet formation
independent of its atherogenicity
To investigate the origin of the heterogeneity in the
atherogenicity of TGRL isolated from blood collected following
consumption of a high-fat meal, we recruited thirty-four
subjects with normal fasting glucose, but exhibiting a broad
range in anthropometric characteristics and fasting serum
triglycerides from normal to hypertriglyceridemic (Tables S1
and S2). We categorized each subject’s postprandial TGRL
based on its capacity to alter the inflammatory response of
HAEC stimulated with TNFα, a pivotal inflammatory cytokine
expressed locally at sites of atherosclerotic plaques [28] and a
biomarker for CVD that is found at elevated levels in the serum
of individuals at increased risk [29]. The dose of TNFα in use
(0.3 ng/ml) was previously reported to correspond to the EC50
for upregulation of membrane adhesion receptors on HAEC
(VCAM-1, ICAM-1, or E-selectin) [8]. TGRL that enhanced
VCAM-1 expression relative to TNFα stimulation alone was
designated as pro-atherogenic and that which suppressed
VCAM-1 expression as anti-atherogenic [5,16]. Pro-
atherogenic TGRL were enriched in triglyceride, cholesterol,
ApoE, and ApoCIII content per particle as compared to anti-
atherogenic that uniformly expressed lower levels (Figure S1).
We next investigated whether the differential atherogenic
response of HAEC to inflammatory stimulation was a function
of the extent of TGRL uptake and subsequent lipid droplet (LD)
formation. The internalization of fluorophore-conjugated TGRL
particles increased rapidly upon addition to the EC monolayer
and rose steadily up to 6 hr (Figure 1A), while the uptake rate
reached a steady state after 2 hr (Figure 1A, inset). Intracellular
LD formation was visualized by confocal fluorescence
microscopy of BODIPY stained EC (Figure 1B). Discrete
punctate BODIPY-positive droplets measuring ~0.1-0.5
micrometer in diameter were resolved in HAEC cytoplasm. To
determine whether the rate and extent of LD formation
correlated with TGRL atherogenicity, we quantified their
cytoplasmic abundance using flow cytometry. LD formation
increased with a time course similar to that of TGRL uptake at
a rate that plateaued at 2 hr and maintained a steady state up
to 5 hr (Figure 1C, inset). LD abundance in TGRL treated
HAEC was increased by ~6-fold at 4 hr with no significant
difference observed in the extent of LD formation between anti-
and pro-atherogenic TGRL (Figure 1D), which decreased
VCAM-1 expression by 10 ± 2 %, and increased it by 29 ± 7 %,
respectively, compared to TNFα alone. Noteworthy was the
observation that the extent of LD formation as measured by
BODIPY fluorescence correlated closely with the side scatter
(SSC) signal obtained by flow cytometry (r = 0.94, P < 0.0001,
Figure S2), suggesting that SSC provides a simple label-free
approach to assess LD abundance in EC. Together, these data
demonstrate a rapid and sustained TGRL uptake that results in
the extensive formation of LD in the cytoplasm of HAEC.
Heterogeneity of particle size and composition that
discriminated anti- from pro-atherogenic TGRL did not result in
a discernible difference in the extent of LD formation. We
conclude that the relative atherogenicity of TGRL on HAEC is
not simply a function of its relative abundance or extent of
cytoplasmic internalization.
TGRL atherogenicity is reflected in ER morphological
changes associated with ER stress
Excess fatty acids and sterols released from lipoproteins are
mainly converted to neutral lipids and stored in LD by a series
of ER-resident enzymes [9]. We next examined whether the
atherogenic phenotype induced by uptake and metabolism of
individual TGRL was reflected in alteration of ER [9]. One
readout of ER dysfunction is distortion in the composition and
structure of its membrane, as previously observed in smooth
muscle cells [30] and livers of obese mice fed diets high in fat
[31]. To investigate if the metabolic challenge induced by TGRL
uptake and subsequent LD formation effectively disrupts ER
function, we examined ER morphology after 4 hr incubation
with pro- or anti-atherogenic TGRL or control media in the
presence of TNFα stimulation. HAEC ER morphology was
imaged by confocal microscopy and immunofluorescence
staining of calreticulin, an ER luminal resident protein [32].
Image analysis revealed a significant extent of ER membrane
TGRL Edits VCAM-1 Expression via UPR Pathways
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expansion in HAEC treated with pro-atherogenic TGRL (Figure
2A), similar to that previously reported following skeletal
muscle uptake of saturated fatty acid [30]. ER membrane
expansion was characterized by an increase in tubular and
web structures with a significant 33% increase in the spatial
heterogeneity of labeled calreticulin in HAEC treated with pro-
atherogenic TGRL and stimulated with TNFα (Figure 2B). In
contrast, anti-atherogenic TGRL suppressed ER expansion by
14%. To test whether ER stress was associated with the
differential effects of pro- versus anti-atherogenic TGRL, we
examined ER membrane alteration in the presence of the ER
stress inhibitor, 4-phenyl butyric acid (4-PBA). Treatment with
4-PBA abrogated the effect of pro-atherogenic TGRL on ER
expansion (Figure 2C-D). Further, we confirmed that TNFα
itself did not cause obvious morphological changes compared
to control cells; however, treatment of HAEC with pro-
atherogenic TGRL alone induced a significant increase in ER
expansion that was augmented upon TNFα stimulation (Figure
S3). These data demonstrate that ER membrane morphology
provides a reliable readout of the relative effects of TGRL and
suggest that ER stress may directly influence downstream
inflammatory responses of HAEC.
ER stress plays a key role in TNFα and TGRL
modulation of VCAM-1 expression
The distinct alterations of ER morphology by pro- and anti-
atherogenic TGRL led us to further investigate whether
Figure 1.  TGRL induces extensive lipid uptake and lipid droplet formation.  (A) The kinetics of TGRL uptake. HAEC were
incubated in the presence (“●”) or absence (“○”) of Alexa fluor488-labeled TGRL (10 mg ApoB/dL) for 0-6 hr, and examined for
internalized TGRL by flow cytometry. Data presented as median fluorescence intensity (MFI). Inset: uptake rate defined as ∆MFI/
∆hr. (B) Representative confocal images (i. and zoomed-in version ii.) of lipid droplets formed in HAEC. Cells were treated for 4 hr
with native TGRL (10 mg ApoB/dL) or culture media (“Ctrl”), and stained for lipid droplets with BODIPY 493/503. (C) The kinetics of
lipid droplet formation. HAEC were incubated with native TGRL for designated periods, stained with BODIPY and analyzed by flow
cytometry. n=3. Inset: the rate of lipid droplet formation = ∆MFI of BODIPY/∆hr. (D) Quantification of lipid droplets formed in HAEC
after 4 hr incubation with anti- or pro-atherogenic TGRL. n=3-6. ns, not significant.
doi: 10.1371/journal.pone.0078322.g001
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inhibition of ER stress with 4-PBA would alter TNFα-stimulated
upregulation of adhesion receptor expression. Treatment of
HAEC with 4-PBA significantly inhibited VCAM-1 upregulation
in a dose-dependent manner, yielding an IC50 of 2mM and
~70% inhibition at 3mM 4-PBA following 4 hrs of stimulation
(Figure 3A and Figure S4 A-B). In contrast, 4-PBA did not
affect ICAM-1 upregulation within this dose range (Figure 3A
and Figure S4 C-D). Similar results were observed for
regulation of mRNA production at the 2 hr time point (Figure
3B). This suggested that ER stress was modulating a VCAM-1-
specific regulatory pathway. To determine whether inhibition of
ER stress also modulated the atherogenic effect of TGRL on
VCAM-1 expression, HAEC were treated with pro- or anti-
atherogenic TGRL and stimulated with TNFα in the presence or
absence of 4-PBA. Suppression of ER stress by 4-PBA
abrogated the pro-atherogenic effect of TGRL in regulating
TNFα-stimulated VCAM-1 expression (Figure 3C). These
results clearly implicate ER stress in TNFα and TGRL-
modulated adhesion molecule upregulation.
TGRL modulates VCAM-1 expression through
activation of ER stress
We next investigated the ER stress signaling pathways that
may contribute to the atherogenic effect of TGRL specifically
Figure 2.  TGRL-induced ER morphological changes are alleviated by an ER stress inhibitor.  A-B: Pro-atherogenic TGRL
induces ER expansion, defined as increased spatial heterogeneity (Standard Deviation/Mean of pixel fluorescence intensity within
cell cytoplasm), while anti-atherogenic TGRL suppresses it. HAEC grown on coverslips were treated for 4 hr with TNFα alone or
simultaneously with pro- or anti-atherogenic TGRL (10 mg ApoB/dL). Cells were then visualized by indirect immunofluorescence
and confocal microscopy. Representative confocal images shown in (A) red, calreticulin; blue, Hoechst nuclear stain. Bottom panels
show zoomed images of calreticulin signal from the boxed 20µm × 5µm region. Statistical analysis of ER expansion shown in (B).
30-40 cells were analyzed for each condition. ***P<0.001, *P<0.05 from TNFα-stimulated. C-D: ER stress inhibition normalizes
TGRL’s effect on ER morphology. 4-phenyl butyric acid (4-PBA) was added to the above treatments with additional 1 hr
pretreatment. Confocal images shown in (C) and statistical analysis in (D). 30-40 cells were analyzed for each condition. ns, not
significant.
doi: 10.1371/journal.pone.0078322.g002
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on VCAM-1 expression. We first measured changes in BiP
protein expression and the phosphorylation of IRE1α (Ser724)
and eIF2α (Ser51), adjusted for their relative levels of protein
expression. Western immunoblotting revealed that TNFα at 0.3
ng/ml elicited 80% upregulation of BiP expression and 50% of
IRE1α phosphorylation over baseline, which equals 42% and
58% of the elevation by TNFα at 10 ng/ml (Figure S5). Pro-
atherogenic TGRL on average upregulated BiP expression by
~80% and increased the phosphorylation of both IRE1α (35%)
and eIF2α (15%) from the modest effect of TNFα alone,
whereas anti-atherogenic TGRL had comparatively less of an
effect on BiP and IRE1α (Figure 4A-C). Further, a significant
direct correlation was observed in activity of all three ER stress
markers versus regulation of VCAM-1 expression elicited by
treatment with each subject’s TGRL relative to TNFα alone. To
better understand the effect of TGRL on downstream mediators
of ER stress we assessed activation of sXBP1 and CHOP.
Baseline expression of sXBP1 protein was detected at low
levels and not significantly elevated by treatment with TGRL
alone. TNFα stimulation significantly increased the level of
sXBP1, which was further elevated by pro-atherogenic TGRL
(15%) and decreased by anti-atherogenic TGRL (63%) relative
to TNFα stimulation alone (Figure 4D). In contrast, baseline
expression of CHOP was increased by 80% following treatment
with pro-atherogenic TGRL, but remained unchanged in
response to anti-atherogenic TGRL. TNFα stimulation alone
increased CHOP expression by 3-fold and this rise was
suppressed by anti-atherogenic TGRL (Figure 4E). Both
sXBP1 and CHOP levels significantly correlated with regulation
of VCAM-1 expression elicited by treatment with each subject’s
TGRL compared to TNFα alone (Figure S6). As expected,
inhibition with 4-PBA down regulated cytokine activation of ER
stress as indicated by an attenuated phosphorylation of IRE1α
and reduced expression of CHOP and sXBP1 (Figure 4F).
These results indicate that ER stress and activation of the UPR
is directly influenced by stimulation with TNFα and its activity
further modulates VCAM-1 expression as a function of the
relative atherogenicity of TGRL.
IRF-1-regulation of VCAM-1 expression correlates with
TGRL-induced ER stress response
To connect TGRL-modulated ER stress pathways to altered
VCAM-1 expression, we analyzed changes in the expression of
interferon regulatory factor 1 (IRF-1) with concomitant changes
in ER stress markers over a range in activity from anti- to pro-
atherogenic. The motivation for this set of experiments was our
recent report that IRF-1 parallels inflammatory changes in
VCAM-1 expression as a function of the atherogenicity of a
subject’s TGRL [5]. Moreover, studies with siRNA have
revealed that IRF-1 activity directly correlated with the up or
down modulation of TGRL on VCAM-1 expression by
regulating Vcam-1 transcription [5]. In the current cohort, we
confirmed that IRF-1 expression strongly correlated with
regulation of VCAM-1 expression in response to TGRL (Figure
S7 A). Like VCAM-1 expression, IRF-1 protein levels in HAEC
were directly and significantly correlated with IRE1α and eIF2α
phosphorylation as modulated by TGRL from our subject pool
(Figure 5A-B). TGRL that promoted sXBP1 upregulation by
20% and CHOP by 24% in response to TNFα, increased IRF-1
expression on average by 23%. Conversely, TGRL that
suppressed sXBP1 upregulation by 63% and CHOP by 43%,
reduced IRF-1 expression by 28%. The specificity in regulation
of IRF-1 was assessed by pretreatment of HAEC over a dose
range of 4-PBA, which revealed a decrease in TNFα-stimulated
IRF-1 protein expression stimulated with TNFα for 4 hr (Figure
5C). Similar to inhibition of VCAM-1, we detected an IC50 of ~1
Figure 3.  ER stress plays a key role in TGRL modulation of TNFα-stimulated VCAM-1 expression.  A-B: ER stress inhibition
dose-dependently reduced TNFα-induced VCAM-1 expression but did not affect ICAM-1 expression. HAEC were conditioned for 4
hr (A) or 2 hr (B) with TNFα (0.3 ng/ml) and 4-phenyl butyric acid (4-PBA) at different doses (0, 0.3, 1, or 3 mM, with 1 hr
pretreatment). VCAM-1 and ICAM-1 protein or mRNA expression analyzed by flow cytometry (A) or quantitative RT-PCR (B). n=3-5.
*P<0.05, **P<0.01 from TNFα stimulated alone. (C) ER stress inhibition abolished TGRL modulation of TNFα-stimulated VCAM-1
expression. HAEC were treated for 4 hr with TNFα (0.3 ng/ml) alone or simultaneously with pro- or anti-atherogenic TGRL (10 mg
ApoB/dL) in the presence (1 mM, 1 hr pretreatment and 4 hr co-treatment) or absence of 4-PBA. n=4-7. ***P<0.001, **P<0.01 from
TNFα-stimulated alone. ns, not significant.
doi: 10.1371/journal.pone.0078322.g003
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mM and maximal suppression of IRF-1 protein production of
60% above 3mM (Figure 5C). Consistently, pretreatment of
cells with 4-PBA at 1 mM significantly inhibited Irf-1
transcription at 1 hr post stimulation with TNFα (Figure S8).
Depletion of IRF-1 with siRNA decreased TNFα-induced
VCAM-1 expression at both mRNA and protein levels (Figure
S7 B-C). In contrast, activation of NF-κB and AP-1, two other
transcription factors of Vcam-1 that are activated by TNFα
stimulation, was not affected by 4-PBA up to doses of 1 mM
(Figure S9). This is consistent with our observation that ICAM-1
expression, which is primarily regulated by NF-κB and AP-1, is
not significantly altered by 4-PBA treatment (Figure 3A-B). We
conclude that IRF-1 activity is coupled to an ER stress
response pathway that links TGRL metabolism with
inflammatory regulation of VCAM-1 in HAEC.
Figure 4.  TGRL modulates ER stress markers as a function of its atherogenicity.  HAEC were treated for 4 hr with TNFα
alone or simultaneously with TGRL (10 mg ApoB/dL). Protein extracts from whole cell lysates were analyzed by Western
immunoblot. Representative blots are shown. A-C: Protein expression level or phosphorylation ratio presented as % change from
TNFα-stimulated alone. Pearson correlations between TGRL modulation of TNFα-induced VCAM-1 expression and (A) BiP
expression, (B) IRE1α or (C) eIF2α phosphorylation. n = 15-18. Insets: the same data binned into two categories based on TGRL’s
atherogenicity. *P<0.05, **P<0.01 from TNFα. D-E: Pro-atherogenic TGRL enhanced (D) sXBP1 expression, while anti-atherogenic
TGRL suppressed (D) sXBP1 and (E) CHOP expression. ns, not significant. *P<0.05, ***P<0.001 from TNFα-stimulated. #P<0.05
from non-stimulated control. n=3-9. (F) HAEC were treated for 4 hr with TNFα (0.3 ng/ml) with or without pretreatment with 1 mM 4-
PBA, followed by Western blot analysis, representative of 3 separate experiments.
doi: 10.1371/journal.pone.0078322.g004
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CHOP is involved in the regulation of VCAM-1
expression via modulation of IRF-1
To specify the contribution of ER stress to VCAM-1
expression, the UPR downstream effectors sXBP1 and CHOP
were depleted via transfection of siRNA. Western blotting
confirmed successful specific knockdown of either sXBP1 or
CHOP without affecting phosphorylation of IRE1α in response
to TNFα stimulation (Figure 5D-E). We observed that siRNA
suppression of CHOP but not sXBP1 knockdown decreased
VCAM-1 expression (Figure 5D-E), concomitant with a
reduction in IRF-1 expression (Figure 5F). These data are
consistent with the higher propensity of TGRL to enhance
Figure 5.  IRF-1 plays a central role in ER stress-mediated modulation of VCAM-1 expression by TGRL.  A-B: TGRL
modulation of TNFα-induced VCAM-1 expression is positively correlated with IRF-1 expression. TGRL modulation of TNFα-induced
IRF-1 expression positively correlated with the phosphorylation levels of (A) IRE1α and (B) eIF2α. n=11-12. (C) ER stress inhibition
reduced TNFα-induced IRF-1 expression in a dose-dependent manner. HAEC were conditioned for 4 hr with TNFα (0.3 ng/ml) and
4-PBA over a dose range (0-10 mM, with 1 hr pretreatment). IRF-1 protein level characterized by Western blot. Representative blots
are shown. n=3-5. *P<0.05 from TNFα stimulated. D-E: CHOP knockdown (E) and not sXBP1 knockdown (D) decreased TNFα-
induced VCAM-1 expression. n=4. **P<0.01 vs. siCtrl+TNFα. (F) CHOP knockdown decreases VCAM-1 expression concomitantly
with an inhibition on IRF-1 expression. Shown are representative blots from 3 independent experiments with similar results.
doi: 10.1371/journal.pone.0078322.g005
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CHOP expression and implicate it in activation of a pathway
leading from ER stress to regulation of VCAM-1 expression.
Discussion
To elucidate the mechanisms that contribute to the relative
atherogenicity of lipoproteins in the circulation of individuals
who consume a standard high-fat meal, we exposed
endothelial cells derived from human aortas to isolated
postprandial TGRL. Using this model, we recently reported that
TGRL from hypertriglyceridemic subjects exerted a pro-
atherogenic effect on HAEC based upon its capacity to up-
regulate VCAM-1 expression during inflammation [4]. In
contrast, subjects with normal triglycerides produced
postprandial TGRL that elicited a significant decrease in TNFα-
induced VCAM-1 on HAEC [5]. Editing of VCAM-1 expression
by TGRL was precisely controlled at the transcriptional level by
IRF-1 and was of sufficient magnitude to significantly alter
monocyte adhesion to HAEC [5]. In the current study we show
that perturbation of ER function plays a central role in the
modulation of VCAM-1 expression by TGRL. A direct
correlation was measured between ER stress markers and the
regulation of VCAM-1 in response to TGRL. Relief of ER stress
with the pharmacological inhibitor 4-PBA abrogated the pro-
atherogenic effect of TGRL by inhibiting IRF-1. Specifically, the
anti-atherogenic effect of TGRL was recapitulated by depletion
of UPR downstream effector CHOP, but not sXBP1. These
data are the first to demonstrate the modulation of ER stress by
native TGRL in EC and reveal that dietary lipids can
differentially regulate the kinetics of TNFα-induced VCAM-1
expression at least in part through ER stress signaling and
downstream pathways.
VCAM-1 is typically expressed at undetectable levels on
confluent monolayers of HAEC in tissue culture and treatment
with TGRL alone does not elicit its upregulation [4]. However,
the inflammatory response of HAEC to TNFα was modulated
by treatment with postprandial TGRL and its atherogenic effect
was recently reported to increase with particle density of
cholesterol, triglycerides, ApoE and ApoCIII [5]. In the current
study, we observed that TGRL uptake and the extent of LD
formation was independent of TGRL atherogenicity. In light of
our previous report that pro- and anti-atherogenic TGRL are
composed of distinct distributions of fatty acids [5], these data
suggest that the fatty acid and apolipoprotein content of TGRL
and its metabolism in the ER are in part responsible for its
distinct effects on inflammation. Following internalization, fatty
acids and sterols from TGRL metabolism is converted to
neutral lipids and stored in LD. In addition, fatty acids released
from TGRL may influence ER biosynthesis of phospholipids
and be incorporated into ER and LD membranes. The level of
induction of ER stress appears to be related to the nature of
the lipid species. Fatty acid chain length, level of unsaturation,
position of double bonds, and the cis versus trans nature of the
isomers, can all affect lipid-induced disruption of ER
homeostasis and chronic ER stress [33]. For example,
saturated fatty acids (SFA) such as palmitic acid can distort the
composition of lipids constituting the ER membrane thereby
inducing ER swelling and expansion [30,31,34,35]. In contrast,
monounsaturated fatty acids (MUFA), such as oleic acid, do
not induce ER stress, but are able to alleviate and reverse ER
expansion and ER stress induced by SFA [30,35,36].
We observed that TNFα stimulation alone induced from
~50% to 3-fold increase in BiP expression, IRE1α and eIF2α
phosphorylation, and downstream effectors, sXBP1 and
CHOP. Inhibition of TNFα-induced ER stress with 4-PBA
suppressed VCAM-1 expression without affecting ICAM-1
expression, suggesting a specific regulatory role of ER stress
in VCAM-1 upregulation. A noteworthy observation is that
treatment with pro-atherogenic TGRL alone induced ER
expansion, albeit to a lesser extent than when combined with
TNFα stimulation. Yet such perturbation of ER did not result in
significant elevation of all ER stress markers; only CHOP
expression registered a significant 1-fold increase compared to
untreated control. This is consistent with CHOP being highly
inducible in response to ER stress [37], and suggests that pro-
atherogenic TGRL itself may prime HAEC for an ER stress
susceptive state.
UPR signaling consists of three branches that are initiated by
the ER transmembrane protein sensors: IRE1α, PERK and
ATF6. Activation of ER stress sensors leads to the transcription
of UPR target genes through their proximal downstream
effectors, such as sXBP1, the translation initiation factor eIF2α,
CHOP, and p50-ATF6. Our studies reveal that IRE1α-sXBP1
and PERK-eIF2α are two UPR branches that correlated closely
with TGRL’s effect on VCAM-1 upregulation. Phosphorylated
IRE1α removes a 26-base intron from XBP1 mRNA, yielding
the active transcription factor, sXBP1. Although we observed
that the extent of IRE1α phosphorylation and sXBP1
expression correlated directly with the relative change in
VCAM-1 expression for a given pro- or anti-atherogenic TGRL,
we failed to establish a causal relationship between sXBP1 and
VCAM-1 expression. Knockdown of sXBP1 that greatly
suppressed TNFα-induced VCAM-1 in bone marrow stromal
cells [38] caused no obvious reduction in TNFα-induced
endothelial VCAM-1 upregulation in our study. This
discrepancy may suggest specific regulation of ER stress in
different cell types. Another transcription factor induced during
ER stress is CHOP, which has been reported to mediate
apoptosis induction under ER stress and play a role in
atherogenesis [24]. It was reported that CHOP deficiency
markedly suppressed expression of inflammation and adhesion
related proteins including VCAM-1, IL-6, IL-1β, and MCP-1 in
macrophages, EC and smooth muscle cells, and significantly
reduced atherosclerotic plaque formation in high-fat diet fed
ApoE-/- mice [24]. In addition, deletion of CHOP in a murine
model of inflammatory bowel disease significantly lowered
mRNA expression of VCAM-1 and CD11b compared with wild
type mice, but had no effect on expression of other adhesion
molecules [39]. In line with these results, we found anti-
atherogenic TGRL significantly suppressed CHOP expression
induced by TNFα. Moreover, specific knockdown of CHOP
mimicked the effect observed in anti-atherogenic TGRL on
VCAM-1 expression.
It was previously reported that IRF-1 functioned as a specific
transcriptional regulator of VCAM-1 expression in response to
TGRL [5]. The current dataset confirmed that IRF-1 protein
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level strongly correlated with the regulation of VCAM-1
expression by TGRL. Moreover, IRF-1 expression directly
correlated with TGRL-modulated eIF2α phosphorylation and
was specifically regulated by the downstream effector CHOP,
indicating that the PERK-eIF2α-CHOP pathway is involved in
IRF-1 regulation. To analyze a link between this pathway and
VCAM-1 transcription, we performed an in silico bioinformatics
analysis of transcription factor binding sites on the promoter
region of Irf-1 using MatInspector from Genomatix. This
revealed two putative CHOP binding sites. Analysis of the
Vcam-1 promoter region also revealed two putative CHOP
sites. These findings suggest that CHOP may regulate
VCAM-1 expression by altering IRF-1 transcription or by
directly binding to the Vcam-1 promoter region. While the
results that 4-PBA decreases IRF-1 and VCAM-1 transcription
support this possibility, future experimental analysis of CHOP
binding to IRF-1 and VCAM-1 promoters using a CHiP assay
will be necessary to elucidate the transcriptional mechanisms
that function downstream of UPR pathways.
In summary, we reveal a putative mechanism by which
dietary lipids can modulate inflammatory activation of VCAM-1
expression on HAEC through regulation of ER stress and UPR
pathways. A systematic analysis of IRE1α, PERK/eIF2α and
the proximal effector CHOP, reveal a close correlation with
IRF-1 expression, which is known to regulate VCAM-1 as a
function of TGRL atherogenicity. Specific knockdown with
siRNA further suggest an important role of the PERK/eIF2α/
CHOP pathway in IRF-1-mediated VCAM-1 expression.
Inhibition of ER stress with 4-PBA greatly suppressed the
increased VCAM-1 expression induced by pro-atherogenic
TGRL, but only moderately lowered TGRL’s anti-atherogenic
activity, suggesting that therapeutics targeting ER stress may
provide efficacious treatment of atherosclerosis.
Supporting Information
Figure S1.  TGRL atherogenicity correlates with its particle
contents. TGRL atherogenicity, defined as the ability to
positively (pro-) or negatively (anti-) modulate TNFα (0.3 ng/
ml)-induced VCAM-1 expression in HAEC at 4 hr, correlated
with its particle contents: A) Triglyceride, B) Cholesterol, C)
ApoE, and D) ApoCIII. Linear regression to data for n=13-16.
Data were a representative subset of pro- and anti-atherogenic
subjects, consisting of an approximately equal number of
males and females.
(JPG)
Figure S2.  Cellular lipid droplet content measured by
BODIPY correlates with the side scatter (SSC) signal by
flow cytometry. HAEC were treated with control media or
TGRL at 10 mg ApoB/dL for periods varying from 15 min up to
8 hr, and were then washed and stained with BODIPY. The
side scatter (SSC) profile and fluorescence from cells were
measured by flow cytometry. Pearson correlation. MFI, median
fluorescence intensity.
(JPG)
Figure S3.  Pro-atherogenic TGRL-induced ER
morphological changes are exacerbated in the presence of
TNFα. HAEC grown on coverslips were treated for 4 hr with
pro-atherogenic TGRL (denoted as “pro-”, 10 mg ApoB/dL) or
control media in the presence or absence of TNFα at 0.3 ng/ml.
Cells were then visualized by indirect immunofluorescence and
confocal microscopy. Representative confocal images shown in
A: red, calreticulin; blue, Hoechst nuclear stain. Bottom panels
show zoomed images of calreticulin signal from the boxed
20µm x 5µm region. The extent of ER alterations was
evaluated by spatial heterogeneity (standard deviation/mean of
pixel fluorescence intensity within cell cytoplasm). Statistical
analysis of ER expansion shown in B. n= 20-35. ***P<0.001,
*P<0.05 from non-stimulated.
(JPG)
Figure S4.  Representative FACS histograms and CDF
graphs of fluorescence intensity of VCAM-1 and ICAM-1 in
response to TNFα and PBA. ER stress inhibition dose-
dependently reduced TNFα induced VCAM-1 expression (A-B)
but did not affect ICAM-1 expression (C-D). HAEC were
conditioned for 4 hr with TNFα (0.3 ng/ml) and 4-phenyl butyric
acid (PBA) at different doses (0, 0.3, 1, or 3 mM, with 1 hr
pretreatment).
(JPG)
Figure S5.  TNFα dose effect on ER stress response. HAEC
were treated with TNFα at 0, 0.3 or 10 ng/ml for 4 hr prior to
Western Blot analysis for BiP expression (A) and IRE1α
phosphorylation (B). n=3 *P<0.05; **P<0.01 vs. non-stimulated.
(JPG)
Figure S6.  TGRL modulates sXBP1 and CHOP as a
function of its atherogenicity. HAEC were treated for 4 hr
with TNFα alone or simultaneously with TGRL (10 mg ApoB/
dL). Pearson correlations between TGRL modulation of TNFα-
induced VCAM-1 expression and (A) sXBP1 and (B) CHOP
expression.
(JPG)
Figure S7.  IRF-1 mediates TGRL modulation of TNFα-
induced VCAM-1 expression. (A) TGRL modulation of TNFα-
induced VCAM-1 expression correlates with IRF-1 expression.
HAEC were treated for 4 hr with TNFα alone or simultaneously
with TGRL (10 mg ApoB/dL). VCAM-1 membrane expression
analyzed by flow cytometry and IRF-1 by Western blot. Protein
expression levels presented as % change from TNFα-
stimulation. Pearson correlation. (B-C) Knockdown of IRF-1
decreases VCAM-1 expression at both protein and mRNA
levels. HAEC were transfected with control (siCtrl) or IRF-1
siRNA. At 48-72 hr post-transfection, cells were treated with
TNFα (0.3 ng/ml). VCAM-1 expression was analyzed with
quantitative RT-PCR for mRNA level (B, n=4), or flow
cytometry analysis for VCAM-1 cell surface expression (C,
n=4).
(JPG)
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Figure S8.  Relief of ER stress with 4-PBA inhibits IRF-1
transcription. HAEC were pretreated with 1mM 4-phenyl
butyric acid (4-PBA) for 1 hr followed by stimulation with 0.3
ng/mL TNFα for 30 min or 1 hr. IRF-1 mRNA was quantified
with quantitative RT-PCR. Paired Student’s t test. *P<0.05.
(JPG)
Figure S9.  4-PBA does not affect TNFα-induced NF-κB and
AP-1 activity. Activation of (A) NF-κB (phospho-p65) and (B)
AP-1 (phosphorylated c-Jun) was measured by ELISA in
nuclear extract of HAEC treated for 30 min with 4-PBA over a
dose range of 0-10 mM simultaneously with TNFα (0.3 ng/ml).
(A) n=3-6. ns, not significant. RLU, relative light unit. (B) n=4-6.
*P<0.05; **P<0.01 vs. TNFα stimulated.
(JPG)
Table S1.  Anthropometric characteristics of study
participants.
(DOCX)
Table S2.  Fasting and postprandial glucose and
cholesterol levels of subjects.
(DOCX)
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